Aytu BioPharma, Inc. (AYTU) Earnings Call Transcript & Summary

Ladies and gentlemen, thank you for standing by, and welcome to the Aytu BioScience, Inc. conference call. I would now like to hand the conference over to your speaker today, Josh Disbrow, Chief Executive Officer. Please go ahead.

Thank you. Good morning. This is Josh Disbrow, Chairman and CEO of Aytu BioScience, and it's my pleasure to welcome you to the special meeting of stockholders. The meeting will now come to work. The business before this meeting is described in our notice of special meeting of stockholders and proxy statement, a copy of which has been mailed to our stockholders. This meeting is being held in accordance with Aytu's bylaws and Delaware law. A copy of the agenda and rules of conduct for the meeting has been provided through the web portal. It is our intention to conduct this meeting in accordance with these documents. There will be an opportunity for questions about all of the proposals prior to voting. Please adhere to the rules of conduct attached to your agenda in addressing this meeting in connection with the proposals. If you have sent in a proxy, your vote will be counted automatically without any further action on your part. If you are eligible to vote and have not submitted your proxy or if you want to change your vote, please click on the stockholder ballot link on the web portal and follow the instructions. The inspector of elections has advised that a quorum is present at the meeting. After the review of the proposals, we will provide time for questions pertinent only to meeting matters. Only validated stockholders may ask questions through the Ask a Question box located on the meeting website. Out of consideration for others, please limit yourself to 2 questions. The first item of business stated in the notice of special meeting of stockholders is a vote to approve, for the purposes of compliance with the Nasdaq rules, the consideration to be delivered by Aytu in connection with the merger of Neos Therapeutics, Inc., with a wholly owned subsidiary of Aytu, the merger in such consideration, the "merger consideration." The merger consideration will consist of: one, shares of Aytu common stock issued in connection with the merger; and two, payment of cash in lieu of the issuance of fractional shares of Aytu common stock, such proposal, the "merger consideration proposal." 98.1% of the total votes prior -- voted prior to this meeting have voted in favor of this proposal. The name change proposal. The next order of business is to approve the amendment to Aytu certificate of incorporation to change the corporate name of Aytu from Aytu BioScience, Inc. to Aytu Biopharma, Inc., effective upon the filing of the amendment to Aytu certificate of incorporation with the Secretary of State of the State of Delaware after consummation of the merger. Such proposal the "name change proposal." 99.1% of the total shares voted prior to this meeting have voted in favor of this proposal. The adjournment proposal. The next order of business is to approve the adjournment or postponement from time to time of the Aytu special meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes to approve the merger consideration proposal and/or the name change proposal, the "adjournment proposal." 96.7% of the total votes to shares voted prior to this meeting have voted in favor of this proposal. We will now open the floor to questions concerning the matters to be voted on. If you would like to ask a question, again, please enter them through the Ask a Question box located on the meeting website. It is now 10:04 Mountain Time, and the polls for each matter to be voted on at this special meeting are now open. Stockholders who are voting via the web portal, please submit your vote now. You must submit your votes via the web portal now in order for them to be counted. The inspector of elections will not accept proxies or votes or any changes or revocations submitted after the closing of the polls. Pursuant to their standard procedures, the inspector of elections will tabulate the votes in accordance with such procedures. The results of the balloting will be certified by the inspector of elections. Upon certification, the company will publicly announce the results of the voting on items presented at this meeting. [Voting]

It is now 10:05 Mountain Time. The polls are now closed, and the meeting is now adjourned. This ends the formal portion of our meeting. I'd like to express my sincere appreciation to the stockholders who attended the meeting and voted as well as those who submitted their proxies but were not able to be present virtually. Thank you very much.

Thank you. Ladies and gentlemen, this concludes today's conference call. Thank you for participating. You may now disconnect.